title: [Therapeutic options in age-related exudative macular degeneration].
abstract: The age-related macular disease (AMD) is the most frequent cause for blindness over 65 years in the developed countries. The incidence of this pathology (Framingham study) is: 2% (52-64 old), 11 %(65-74 old), 28%(>75 old). Our paper wants to review the therapeutic armamentarium during the last twenty years for treating Wet AMD--the most serious form of this disease.
authors.affiliation: Spitalul Militar de Urgenta Prof. Dr. Agrippa Ionescu.
authors.forename: Horia T
authors.initials: HT
authors.lastname: Stanca
mesh_terms: D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D020533:Angiogenesis Inhibitors / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006801:Humans; D017075:Laser Coagulation / Q000379:methods; D053685:Laser Therapy / Q000379:methods; D008268:Macular Degeneration / Q000453:epidemiology / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy*; D012383:Romania / Q000453:epidemiology; D014821:Vitrectomy / Q000379:methods
chemical_list: D000305:Adrenal Cortex Hormones; D020533:Angiogenesis Inhibitors